3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Multiple Myeloma
338
Neoplasms, Plasma Cell
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Recurrence
50
Lymphoma
48
Leukemia
39
Neoplasms
27
Lymphoma, Mantle-Cell
27
Burkitt Lymphoma
26
Lymphoma, Large B-Cell, Diffuse
23
Immunoglobulin Light-chain Amyloidosis
23
Lymphoma, Non-Hodgkin
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
17
Leukemia, Lymphocytic, Chronic, B-Cell
16
Hodgkin Disease
14
Nausea
12
Lymphoma, Extranodal NK-T-Cell
12
Lymphoma, B-Cell, Marginal Zone
12
Vomiting
11
Smoldering Multiple Myeloma
11
Prostatic Neoplasms
11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Breast Neoplasms
11
Renal Insufficiency
10
Neoplasm Metastasis
9
Lymphoma, Large-Cell, Immunoblastic
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Leukemia, Biphenotypic, Acute
7
Interventions
Cisplatin
51
Gemcitabine
26
toripalimab
20
Radiotherapy, Intensity-Modulated
19
Fluorouracil
16
Capecitabine
16
camrelizumab
15
Docetaxel
14
nimotuzumab
12
Radiotherapy
10
Drug Therapy
10
apatinib
9
Nivolumab
9
sintilimab
8
endostar protein
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Immune Checkpoint Inhibitors
7
tislelizumab
6
spartalizumab
6
Chemoradiotherapy
6
Cetuximab
6
Bevacizumab
6
pembrolizumab
5
nedaplatin
5
S 1 (combination)
5
Radiation
5
Paclitaxel
5
Endostatins
5
anlotinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Nasopharyngeal Carcinoma
×
Dexamethasone
×
Clear all
NCT00953420
2017-08-18
CADEN
Baylor College of Medicine
Phase 2
Completed
20 enrolled